First Time Loading...

GeneDx Holdings Corp
NASDAQ:WGS

Watchlist Manager
GeneDx Holdings Corp Logo
GeneDx Holdings Corp
NASDAQ:WGS
Watchlist
Price: 27.28 USD 0.89% Market Closed
Updated: Jun 13, 2024
Have any thoughts about
GeneDx Holdings Corp?
Write Note

GeneDx Holdings Corp
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

GeneDx Holdings Corp
Cost of Revenue Peer Comparison

Comparables:
DVA
DGX
CVS
CI
LH

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
GeneDx Holdings Corp
NASDAQ:WGS
Cost of Revenue
-$112.6m
CAGR 3-Years
15%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
DaVita Inc
NYSE:DVA
Cost of Revenue
-$8.3B
CAGR 3-Years
-2%
CAGR 5-Years
-1%
CAGR 10-Years
0%
Quest Diagnostics Inc
NYSE:DGX
Cost of Revenue
-$6.2B
CAGR 3-Years
0%
CAGR 5-Years
-5%
CAGR 10-Years
-4%
CVS Health Corp
NYSE:CVS
Cost of Revenue
-$307.3B
CAGR 3-Years
-23%
CAGR 5-Years
-15%
CAGR 10-Years
-11%
Cigna Corp
NYSE:CI
Cost of Revenue
-$180.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Laboratory Corporation of America Holdings
NYSE:LH
Cost of Revenue
-$8.9B
CAGR 3-Years
2%
CAGR 5-Years
-2%
CAGR 10-Years
-9%

See Also

What is GeneDx Holdings Corp's Cost of Revenue?
Cost of Revenue
-112.6m USD

Based on the financial report for Dec 31, 2023, GeneDx Holdings Corp's Cost of Revenue amounts to -112.6m USD.

What is GeneDx Holdings Corp's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-4%

Over the last year, the Cost of Revenue growth was 57%. The average annual Cost of Revenue growth rates for GeneDx Holdings Corp have been 15% over the past three years , -4% over the past five years .